Drug: |
PLX3397 (PLX108-01) |
|||
---|---|---|---|---|
Trial: |
Safety Study of PLX108-01 in Patients With Solid Tumors |
|||
Conditions: | Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
TGen Clinical Research Services10460 N. 92nd Street, Suite 206 |
Principal Investigator: |
Daniel D. Hoff, MD |
---|---|
Contact: |
TGen Clinical Research Services Cancer Care Coordinator 877-273-3713 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
TGen Clinical Research Services Website: |
http://www.tgen.org/research/index.cfm?pageid=1085 |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.